OPKO Health, Inc.
$1.51B- Market cap
- $1.19B
- Debt
- +$687.93M
- Cash
- −$364.41M
Capital structure 63% equity / 37% debt · EV / Revenue 2.49x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt cap
Decision snapshot: OPK stock price at discount vs XPO $1.59 current versus $2.22 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at XPO's multiple
Implied fair value · at OPK's multiple
Snapshot Sep 8, 2026, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: OPK FY 2025 (ended Dec 31, 2025) · XPO FY 2025 (ended Dec 31, 2025).
Trendline
13 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
Market cap plus debt, less cash.
Capital structure 63% equity / 37% debt · EV / Revenue 2.49x
Capital structure 87% equity / 13% debt · EV / Revenue 3.11x · EV / EBITDA 35.01x
XPO carries the larger enterprise value at $25.35B against $1.51B; OPK trades on the lower EV / Revenue multiple (2.49x vs 3.11x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
OPKO Health, Inc. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
XPO, Inc. · implied price per share
Bear
-$17.35
Base
-$15.65
Bull
-$13.36
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.54x
1.83x
Net debt / EBITDA
Leverage against operating earnings
-3.03x
4.28x
Cash and equivalents
Liquid reserves on the balance sheet
$364.41M
$310.00M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
AMARIN CORP PLC\UK
OPK vs AMRN
Sarepta Therapeutics, Inc.
OPK vs SRPT
Amphastar Pharmaceuticals, Inc.
OPK vs AMPH
SUPERNUS PHARMACEUTICALS, INC.
OPK vs SUPN
Harmony Biosciences Holdings, Inc.
OPK vs HRMY
C. H. ROBINSON WORLDWIDE, INC.
OPK vs CHRW
Hub Group, Inc.
OPK vs HUBG
SAIA INC
OPK vs SAIA
OLD DOMINION FREIGHT LINE, INC.
OPK vs ODFL
FEDEX CORP
OPK vs FDX
UNITED PARCEL SERVICE INC
OPK vs UPS
$687.93M
$3.41B
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.